These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7590519)

  • 81. SL25.1131 [3(S),3a(S)-3-methoxymethyl-7-[4,4,4-trifluorobutoxy]-3,3a,4,5-tetrahydro-1,3-oxazolo[3,4-a]quinolin-1-one], a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B: biochemical and behavioral profile.
    Aubin N; Barneoud P; Carter C; Caille D; Sontag N; Marc C; Lolivier J; Gardes A; Perron C; Le Kim A; Charieras T; Pandini M; Burnier P; Puech F; Jegham S; George P; Scatton B; Curet O
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1171-82. PubMed ID: 15178694
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Characterization of oral microbiota in marmosets: Feasibility of using the marmoset as a human oral disease model.
    Takehara S; Zeredo JL; Kumei Y; Kagiyama K; Fukasawa K; Oshiro A; Ueno M; Kojimahara N; Minakuchi S; Kawaguchi Y
    PLoS One; 2019; 14(2):e0207560. PubMed ID: 30730898
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The common marmoset in biomedical research: experimental disease models and veterinary management.
    Inoue T; Yurimoto T; Seki F; Sato K; Sasaki E
    Exp Anim; 2023 May; 72(2):140-150. PubMed ID: 36436909
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Overview of the marmoset as a model in nonclinical development of pharmaceutical products.
    Orsi A; Rees D; Andreini I; Venturella S; Cinelli S; Oberto G
    Regul Toxicol Pharmacol; 2011 Feb; 59(1):19-27. PubMed ID: 21156195
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The metabolome as a biomarker of mortality risk in the common marmoset.
    Hoffman JM; Ross C; Tran V; Promislow DEL; Tardif S; Jones DP
    Am J Primatol; 2019 Feb; 81(2):e22944. PubMed ID: 30585652
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Marmoset colony set to grow in Texas.
    Neff EP
    Lab Anim (NY); 2019 Sep; 48(9):243. PubMed ID: 31388137
    [No Abstract]   [Full Text] [Related]  

  • 87. Developing biomarkers for neurodegenerative diseases using genetically-modified common marmoset models.
    Tomioka I; Nagai Y; Seki K
    Neural Regen Res; 2018 Jul; 13(7):1189-1190. PubMed ID: 30028324
    [No Abstract]   [Full Text] [Related]  

  • 88. [Dermal application of lisuride on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset and on cases with Parkinson's disease].
    Nomoto M; Iwata S; Irifune M; Kaseda S; Osame M; Fukuda T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Jun; 18(3):81-7. PubMed ID: 9800199
    [TBL] [Abstract][Full Text] [Related]  

  • 89. A selective MAOB inhibitor Ro19-6327 potentiates the effects of levodopa on parkinsonism induced by MPTP in the common marmoset.
    Nomoto M; Fukuda T
    Neuropharmacology; 1993 May; 32(5):473-7. PubMed ID: 8321428
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
    J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Chronic L-DOPA administration induces dyskinesias in the 1-methyl-4- phenyl-1,2,3,6-tetrahydropyridine-treated common marmoset (Callithrix Jacchus).
    Pearce RK; Jackson M; Smith L; Jenner P; Marsden CD
    Mov Disord; 1995 Nov; 10(6):731-40. PubMed ID: 8749992
    [TBL] [Abstract][Full Text] [Related]  

  • 92. [Application of the common marmoset to pharmacological studies].
    Nomoto M
    Nihon Yakurigaku Zasshi; 1995 Jul; 106(1):11-8. PubMed ID: 7590519
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Marmoset monkey models of Parkinson's disease: which model, when and why?
    Eslamboli A
    Brain Res Bull; 2005 Dec; 68(3):140-9. PubMed ID: 16325013
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.